false
--03-31
2025
Q2
0001867072
0001867072
2025-04-01
2025-09-30
0001867072
2025-10-29
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q/A
(Amendment No. 1)
x QUARTERLY
REPORT PURSUANT TO SECTION 13 or 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30,
2025
OR
¨ TRANSITION
REPORT PURSUANT TO SECTION 13 or 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM _________________
TO _________________
001-40853
(Commission file number)
Kyndryl Holdings,
Inc.
(Exact name of registrant as specified in its charter)
| Delaware |
86-1185492 |
| (State or other jurisdiction of incorporation or organization) |
(IRS employer identification number) |
| |
|
| One Vanderbilt Avenue, 15th Floor |
|
| New York, New York |
10017 |
| (Address of principal executive offices) |
(Zip Code) |
855-596-3795
(Registrant’s telephone number, including
area code)
N/A
(Former name, former address and former fiscal
year, if changed since last report)
Securities registered pursuant to Section 12(b) of
the Act:
| Title of each class |
Trading symbol(s) |
Name of each exchange
on which registered |
| Common stock, par value $0.01 per share |
KD |
New York Stock Exchange |
Indicate by check mark whether the registrant (1) has
filed all reports required to be filed by Section l3 or l5(d) of the Securities Exchange Act of 1934 during the preceding 12
months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has
submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨
Indicate by check mark whether the registrant is
a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer x |
Accelerated filer ¨ |
| Non-accelerated filer ¨ |
Smaller reporting company ¨ |
| |
Emerging growth company ¨ |
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is
a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
The number of shares of the registrant’s
Common Stock, par value $0.01 per share, outstanding as of October 29, 2025 was 228,564,347.
Index
| |
Page |
| Explanatory Note |
|
| Part I - Financial Information: |
|
| Item 4. Controls and Procedures |
4 |
| Part II - Other Information: |
|
| Item 6. Exhibits |
6 |
| SIGNATURES |
7 |
EXPLANATORY NOTE
In connection with the
review by Kyndryl Holdings, Inc. (the “Company”), through the Audit Committee of its Board of Directors (the “Board”),
of its cash management practices, related disclosures, the efficacy of the Company’s internal control over financial reporting, and
certain other matters, the Company re-assessed the effectiveness of its disclosure controls and procedures and internal control over
financial reporting as of March 31, 2025. As disclosed in the Company’s Amendment No. 1 to Annual Report on Form 10-K filed with the
Securities and Exchange Commission (“SEC”) on February 17, 2026 (the “Form 10-K Amendment”), the Company determined that
there were material weaknesses in the Company’s internal control over financial reporting as of March 31, 2025 and that the
Company’s disclosure controls and procedures and internal control over financial reporting were ineffective as of such date. In
addition, as disclosed in the Company’s Amendment No. 1 to Quarterly Report on Form 10-Q filed with the SEC on February 17, 2026
(the “Form 10-Q Q1 Amendment”), such material weaknesses continued to exist as of June 30, 2025, and as a result, the Company
determined that the Company’s disclosure controls and procedures were ineffective as of such date.
Due to the continued existence of the material weaknesses in the Company’s
internal control over financial reporting disclosed in the Form 10-K Amendment and the Form 10-Q Q1 Amendment as of September 30, 2025,
the Company determined that the Company’s disclosure controls and procedures were also ineffective as September 30, 2025.
As a result, the Company
is filing this Amendment No. 1 (this “Amendment”) to the Company’s Quarterly Report on Form 10-Q for the
quarter ended September 30, 2025, originally filed with the SEC on
November 5, 2025 (the “Original Form 10-Q”), to amend:
| · | Item 4. “Controls and
Procedures” to reflect that the Company’s disclosure controls and procedures were not effective as of September 30, 2025
due to the material weaknesses in the Company’s internal control over financial reporting as of September 30, 2025; and |
| · | Item 6. “Exhibits” to reflect
the new certifications referenced below. |
This Amendment also includes
new currently dated certifications (as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange
Act”)) by the Company’s principal executive officer and principal financial officer.
Notwithstanding the material
weaknesses identified, the Company has concluded that the material weaknesses did not result in misstatements of previously issued historical
consolidated financial statements and that such financial statements continue to present fairly, in all material respects, the Company’s
financial position, results of operations and cash flows as of and for the relevant periods presented in conformity with U.S. generally
accepted accounting principles (“GAAP”).
Pursuant to Rule 12b-15
under the Exchange Act, this Amendment contains only the items of the Original Form 10-Q that are being amended and
the newly dated certifications referenced above. Unaffected items are not included herein. Accordingly, except as set forth herein, this
Amendment does not modify or update disclosures included in the Original Form 10-Q, nor does it reflect events occurring after the
filing of the Original Form 10-Q. Among other things, management’s discussion and analysis of financial condition and
results of operation and the forward-looking statements made in the Original Form 10-Q have not been
revised to reflect events, facts or risks that occurred or became known to the Company after the filing of the Original Form 10-Q,
and any such section or statements should be read in their historical context. Accordingly, this Amendment should be read in conjunction
with the Company’s filings with the SEC that were made subsequent to the filing of the Original Form 10-Q, including the Form 10-K
Amendment, the Form 10-Q Q1 Amendment and amendments to other subsequent filings, if any.
Part I - Financial Information
Item 4. Controls and Procedures
Disclosure Controls and Procedures
The Company’s
management, with the participation of the Chief Executive Officer and the Chief Financial Officer, evaluated the effectiveness of
the Company’s disclosure controls and procedures (as such term is defined in Rule 13a-15(e) of the Exchange Act) as
of September 30, 2025. At the time the Company filed the Original Form 10-Q, management, with the participation of the Chief
Executive Officer and the Chief Financial Officer, concluded that the Company’s disclosure controls and procedures were
effective as of September 30, 2025. Subsequent to the filing of the Original Form 10-Q, management, with the participation of the
Chief Executive Officer and the Interim Chief Financial Officer, determined that due to the material weaknesses in internal control
over financial reporting described immediately below, the Company’s disclosure controls and procedures were not effective as
of September 30, 2025.
Management has concluded that the consolidated financial statements
for the periods covered by and included in the Original Form 10-Q continue to fairly present, in all material respects, the Company’s
financial position, results of operations and cash flows in conformity with GAAP.
Material Weaknesses in Internal Control
over Financial Reporting
A material weakness is a deficiency,
or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material
misstatement of a company’s annual or interim financial statements will not be prevented or detected on a timely basis. The material weaknesses described below did not result in a misstatement
of the Company’s previously issued historical consolidated financial statements; however, these material weaknesses could result
in a misstatement that would result in a material misstatement to the annual or interim consolidated financial statements that would not
be prevented or detected.
The Company identified
the following material weaknesses in its internal control over
financial reporting:
| |
· |
The Company’s senior finance executives failed to set an appropriate
tone at the top based on the principles associated with the control environment component of the COSO framework. Specifically, there was
a lack of transparency with the Company’s Chief Executive Officer, the Audit Committee of the Board and the Board, such that disclosure
processes, including with respect to cash management practices regarding deferring vendor payments quarter to quarter, were impacted.
Additionally, the Company lacked an appropriate complement of finance personnel with sufficient understanding of their responsibilities
as Disclosure Committee members and with adequate competency in their responsibilities regarding disclosure controls. |
| |
· |
The Company did not design and maintain effective controls related
to the information and communication component of the COSO framework to ensure appropriate communication pertaining to the disclosure
process between certain functions within the Company, including the Company’s Disclosure Committee and the Chief Executive Officer,
as well as with the Audit Committee and the Board. |
| |
· |
The aforementioned material weaknesses contributed to an additional
material weakness. The Company did not design and maintain effective controls regarding the internal investigation, escalation and documentation
of complaints made through the Company’s reporting hotline and certain other available reporting channels, including with respect
to appropriate escalation of certain complaints to the Audit Committee. |
Remediation Plan and Activities
The Company has appointed
an Interim Chief Financial Officer, Interim General Counsel and Interim Corporate Controller. In addition, the Company expects to
make the following enhancements to its internal control over financial reporting to remediate the material weaknesses described above:
| · | provide updated training on disclosure controls
and procedures and internal control over financial reporting and requirements under the Sarbanes-Oxley Act of 2002, including training
courses on applicable federal securities laws for members of management; |
| · | enhance the Company’s controls, policies,
procedures and training related to timely and accurate communication and information sharing, including enhancing key controls concerning
information communicated regarding the application of the Company’s cash management practices; |
| · | enhance existing Disclosure Committee
responsibilities to include, among other requirements, additional discussions and provide incremental training on these
responsibilities; and |
| · | enhance the Company’s controls, policies,
procedures and training related to the Company’s reporting hotline, including related to the evaluation and escalation to the Company’s
Audit Committee of certain reports made through the hotline and certain other available reporting channels. |
As the Company continues to
evaluate and work to improve its internal control over financial reporting and disclosure controls and procedures, it may decide to take
additional or different measures to address control deficiencies or modify the remediation actions described above. While the Company
believes that these efforts will improve its internal control over financial reporting, the Company will not be able to conclude whether
the steps the Company is taking will remediate the material weaknesses in internal control over financial reporting until a sustained
period of time has passed to allow management to test the design and operational effectiveness of the new controls.
Changes in Internal Control over Financial
Reporting
There have been no changes in the Company’s internal control over financial reporting
(as such term is defined in Rule 13a-15(f) of the Exchange Act) that occurred during the quarter ended September 30, 2025 that
have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
Part II - Other Information
Item 6. Exhibits
Exhibit
Number |
Description
of Exhibit |
| 2.1 |
Separation
and Distribution Agreement, dated as of November 2, 2021, by and between International Business Machines Corporation and the
registrant, was filed as Exhibit 2.1 to the registrant’s Current Report on Form 8-K filed on November 4, 2021,
and is hereby incorporated by reference. |
| 3.1 |
Amended
and Restated Certificate of Incorporation of the registrant was filed as Exhibit 3.1 to the registrant’s Current Report
on Form 8-K filed on November 4, 2021, and is hereby incorporated by reference. |
| 3.2 |
Amended
and Restated Bylaws of the registrant, effective January 25, 2023, was filed as Exhibit 3.1 to the registrant’s Current
Report on Form 8-K filed on January 27, 2023, and is hereby incorporated by reference. |
| 31.1 |
Certification
of principal executive officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith) |
| 31.2 |
Certification
of principal financial officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith) |
| 32.1 |
Certification
of principal executive officer, as required by Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith) |
| 32.2 |
Certification
of principal financial officer, as required by Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith) |
| 101.INS |
XBRL Instance
Document - the instance document does not appear on the Interactive Data File because its XBRL tags are embedded within the Inline
XBRL document |
| 101.SCH |
XBRL Taxonomy
Extension Schema Document |
| 101.CAL |
XBRL Taxonomy
Extension Calculation Linkbase Document |
| 101.DEF |
XBRL Taxonomy
Extension Definition Linkbase Document |
| 101.LAB |
XBRL Taxonomy
Extension Label Linkbase Document |
| 101.PRE |
XBRL Taxonomy
Extension Presentation Linkbase Document |
| 104 |
Cover
Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because
its XBRL tags are embedded within the Inline XBRL document |
The agreements
and other documents filed as exhibits to this report are not intended to provide factual information or other disclosure other than with
respect to the terms of the agreements or other documents themselves, and you should not rely on them for that purpose. In particular,
any representations and warranties made by the Company in these agreements or other documents were made solely within the specific context
of the relevant agreement or document and do not apply in any other context or at any time other than the date they were made.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| |
Kyndryl
Holdings, Inc. |
| |
(Registrant) |
| |
|
| Date: February 17,
2026 |
By: |
/s/ Martin J. Schroeter |
| |
|
|
| |
|
Martin J. Schroeter |
| |
|
Chairman of the Board and Chief Executive Officer |
| |
|
(Authorized Signatory) |